SignalXSignalX

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) 8-K Current Report: March 6, 2026

Filed: March 6, 2026
Health Care
Laboratory Analytical Instruments
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Overview

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) 8-K current report filed with SEC EDGAR on March 6, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

  • Item 5.02: Departure/Election of Directors or Officers
  • Item 7.01: Regulation FD Disclosure

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 8-K Mar 6, 2026 Event Analysis

Item 5.02 · Departure/Election of Directors or Officers

  • • Michele Farmer resigning as CAO effective March 21, 2026 — voluntary departure, no severance, no disagreements with company
  • • CFO Jim Gibson absorbs principal accounting officer role with no additional compensation change
  • • Gibson has served as CFO only since 2025 — relatively new in role before taking on expanded responsibilities

Item 7.01 · Regulation FD Disclosure

  • • Settlement with PGI ends patent litigation; PACB pays $8M in Q1 2026, then $5M/year in Q1 2027–2029 (total minimum $23M)
  • • 2027 payment increases by $1M if 2026 revenue ≥$165M, another $1M if ≥$180M — creating a revenue-linked contingent liability up to $25M total
  • • PACB receives worldwide, royalty-free, non-exclusive license to U.S. Patent No. 7,767,441 plus 5.5-year covenant not to sue, binding on PGI successors
  • • Covenant not to sue converts open-ended litigation risk into defined, time-bound protection — reduces uncertainty for PACB's long-read sequencing commercial ecosystem
  • • All mutual claims and counterclaims dismissed; damages releases cover pre-settlement period, eliminating retroactive exposure

Other PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 8-K Filings

8-K Mar 5, 2026

Get deeper insights on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.